Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
about
Beta adrenergic overstimulation impaired vascular contractility via actin-cytoskeleton disorganization in rabbit cerebral arteryTargeted inactivation of Galpha(i) does not alter cardiac function or beta-adrenergic sensitivityEffect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatmentThe ral exchange factor rgl2 promotes cardiomyocyte survival and inhibits cardiac fibrosisTemporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism.The role of exercise testing in the evaluation and management of heart failure.Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.Endogenous sulfur dioxide protects against isoproterenol-induced myocardial injury and increases myocardial antioxidant capacity in rats.Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration.Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction.Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state.Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature.Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.Mouse strain determines cardiac growth potential.Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release.Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisitedMst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosisTSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.Metformin attenuates myocardial remodeling and neutrophil recruitment after myocardial infarction in rat.Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles.Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.The benefits of valsartan in the treatment of heart failure: results from Val-HeFT.Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis.Functional brown adipose tissue limits cardiomyocyte injury and adverse remodeling in catecholamine-induced cardiomyopathy.Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model.Cardiac fibroblasts: friend or foe?Phytochemical screening and evaluation of cardioprotective activity of ethanolic extract of Ocimum basilicum L. (basil) against isoproterenol induced myocardial infarction in ratsTranscriptional control of cardiac fibroblast plasticity.Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.FGF2 modulates cardiac remodeling in an isoform- and sex-specific manner.Evening primrose oil ameliorates platelet aggregation and improves cardiac recovery in myocardial-infarct hypercholesterolemic rats.Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in miceMarrubium vulgare L. methanolic extract inhibits inflammatory response and prevents cardiomyocyte fibrosis in isoproterenol-induced acute myocardial infarction in rats.Merits of non-invasive rat models of left ventricular heart failure.Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy.Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states.Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion.
P2860
Q28482409-4010DCF8-12AC-465F-994C-5C2EF099F459Q28506805-416C798D-8022-48AB-913E-526DCC085F5FQ28566849-7982F83D-3BE0-4915-89DF-F8980EEC0A66Q28594924-7F5C1A79-A8D4-433C-84FB-30DF67CD1BCEQ33656014-954DEE37-E201-4F8F-BA28-FE4D5128AAA9Q33823518-2C89F5E5-D935-4F0C-A777-8A23F9BB2181Q34061092-059C185A-0A85-4705-9B30-8A1A34AE821AQ34132827-3D257812-F8F5-49E7-8095-D4BFC9165334Q34358827-D0056CAF-2A89-42FE-A006-2108997E1EF5Q34362979-9088250A-DC71-484D-AC57-BCAF12B1B6F5Q34600261-0526C2F4-12B9-4D64-8089-017E4E77C9DAQ34661152-B65FD844-612B-42E0-96F2-AD54E0B3EAA7Q34892203-CEDF9648-19C4-459F-B574-AC1DE9D8FF0FQ34935217-3A1C9526-23A6-4CE3-9590-B7731FB256DDQ35017453-FDB711D8-FBF1-4C29-9DD9-98ACC05B7630Q35138063-F14B8D77-E523-4397-BCF1-E7ACE46AFD1AQ35170119-D3CF1744-01C1-4B73-858B-AFEDD74BF8FDQ35192600-7FE01649-E6FE-4472-B621-6BAA94998A9BQ35458684-EE1D8AF4-0A87-46B7-B158-2FFCD2A95039Q35500640-E1C3F05C-38B6-4DCB-BDBB-B8361C2B528DQ35689555-5D351D5C-5998-415B-8E8C-C1C030FBF41BQ35710580-2404C70D-F968-46E8-9C29-1B9B09B6145FQ35728321-29510156-0521-4FA8-B454-93907AB3E691Q35745296-F650B9CA-57EA-4B43-8494-285F59A645C6Q35751292-F85141F2-3C9F-4EF2-94FC-7EA6B3F51760Q36114162-59A08119-29D7-4BAA-B222-392646D95B48Q36389384-BAF4E3DB-76B8-4CDF-AE25-EBB13847B180Q36450335-7DE16A8D-2821-4C59-9680-6251E3AE9563Q36565025-32DAFFA9-F070-4AFC-8438-F496CC36FB29Q36609712-22530A45-BD8A-463B-89C0-9DA249E3C370Q36771475-6D58AA72-DEBF-45E3-8C59-6CA263BF0E32Q37129351-FB8634B7-8821-40C1-B425-C487DF98D7B4Q37307785-32DF4F49-2A42-4367-A7E1-3C4655D01BC1Q37652051-7B09E528-1556-4031-AA2D-8F7DC924935AQ37688764-7D679748-FB08-439D-9DC6-024ABB3FBC50Q37733538-4DD6E386-443B-445C-8D11-FC9A8FEDFC33Q37833553-E3AE83F9-E96F-4002-81A1-3BE1B0A41422Q37951439-162D07CD-98C2-4253-9528-8D84D114E47EQ37983499-4D6C1621-1758-4D70-91E9-518581AC3BEAQ38061830-C3F59D72-CFE6-4915-ACD9-E3F7D31A25C2
P2860
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@ast
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@en
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@nl
type
label
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@ast
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@en
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@nl
prefLabel
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@ast
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@en
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@nl
P2093
P356
P1433
P1476
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis
@en
P2093
P304
P356
10.1161/01.RES.65.3.657
P407
P577
1989-09-01T00:00:00Z